LPL Financial
DMAC icon

LPL Financial’s DiaMedica Therapeutics DMAC Stock Holding History

LPL Financial’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53M Buy
226,050
+28,900
+15% +$229K ﹤0.01% 3758
2025
Q4 		$1.57M Sell
197,150
-6,000
-3% -$44.9K ﹤0.01% 3618
2025
Q3 		$1.4M Buy
203,150
+5,650
+3% +$30.6K ﹤0.01% 3664
2025
Q2 		$770K Buy
197,500
+42,200
+27% +$165K ﹤0.01% 3992
2025
Q1 		$589K Buy
155,300
+3,300
+2% +$18.9K ﹤0.01% 4019
2024
Q4 		$825K Buy
152,000
+11,500
+8% +$54.2K ﹤0.01% 3664
2024
Q3 		$589K Buy
140,500
+123,000
+703% +$454K ﹤0.01% 3858
2024
Q2 		$51.6K Buy
+17,500
New +$48K ﹤0.01% 4835

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM